Spread the loveIn the digital landscape of productivity tools, choosing the right office suite can feel like picking between ...
Benefits of Replimune's skin cancer drug remain unclear due to flaws in the trial design that make it difficult to determine ...
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today provided an update ahead of the Company's upcoming ...
Shares of Capricor Therapeutics lost nearly two-thirds of their value Monday after Food and Drug Administration documents raised the specter of another rejection of the company's proposed cell therapy ...
The new King Alfred swimming pool in Hove offers little for older children and young adults, according to objectors.
MANDI: With climate change fuelling a rise in extreme weather events and slope failures, IIT Mandi researchers have developed an operational landslide early warning system for the Indian Himalayan ...
1.スライド ⇒ pdf形式で保存しました。 pdf.ファイルなので、ダウンロードしていただかないと、見れないんです。もし、「ダウンロードしてもいいよッ」って思ってくださるのであれば ...
MILAN, June 15, 2026 /PRNewswire/ -- Addressing a critical technical limitation in multi-cycle imaging - the reliable adhesion and retention of suspension-derived, non-adherent cells - Tethis S.p.A.
Abstract: Whole Slide Imaging (WSI) has become a gold standard in cancer diagnosis, inspecting multi-scale information from cellular to tissue levels. Processing an entire WSI directly is infeasible ...
Here's the effective U.S. tariff rate after Friday's Supreme Court ruling and new Section 122 levies
U.S. tariff uncertainty is back in the spotlight Monday, threatening to pull stocks lower after last week's Supreme Court ruling against a large group of President Donald Trump's tariffs. Investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results